Human genome editing is not safe for clinical use, but nations must prepare: Report
Lindsay BorthwickSeptember 16, 2020
A highly anticipated report says heritable genome editing, using tools like CRISPR to create edits that can be passed down to future generations, is not yet safe enough for clinical use. But it also provides specific guidance on how nations should prepare for the eventual use of CRISPR or other gene editing tools, defining a translational pathway from research to the clinic.
Other stories mentioning these organizations, people and topics
| Organizations: | Dalhousie University, McGill University, U.K. Royal Society, U.S. National Academies, and World Health Organization (WHO) |
| People: | Dr. Bartha Knoppers and Dr. Françoise Baylis |
| Topics: | Human genome editing and Research ethics |
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.